Blank Bio closes $7.2M seed financing, collaboration with Pacific Biosciences

Blank Bio announced the closing of a $7.2M seed financing and a strategic collaboration with Pacific Biosciences. Blank Bio is building RNA foundation models that learn directly from the molecular complexity of tumor transcriptomes to improve patient-level prediction across oncology. Proceeds from the financing will support continued model development, expanded collaborations with pharmaceutical and diagnostic companies, and new long-read RNA-seq datasets to support applications in biomarkers, clinical trial design, and diagnostics.